HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rosaria Volpini Selected Research

rat adenine receptor

3/2005Evidence for the functional expression and pharmacological characterization of adenine receptors in native cells and tissues.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rosaria Volpini Research Topics

Disease

8Parkinson Disease (Parkinson's Disease)
01/2022 - 04/2005
7Neoplasms (Cancer)
06/2022 - 02/2007
6Neurodegenerative Diseases (Neurodegenerative Disease)
04/2022 - 01/2007
5Asthma (Bronchial Asthma)
06/2022 - 01/2003
4Alzheimer Disease (Alzheimer's Disease)
01/2022 - 01/2003
4Inflammation (Inflammations)
04/2019 - 01/2015
3Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
06/2022 - 01/2018
3Neuroinflammatory Diseases
01/2022 - 01/2020
3Pain (Aches)
01/2020 - 07/2013
3Ischemia
01/2019 - 09/2007
3Central Nervous System Diseases (CNS Diseases)
01/2016 - 03/2007
3Astrocytoma (Pilocytic Astrocytoma)
07/2011 - 03/2005
2Prostatic Neoplasms (Prostate Cancer)
01/2022 - 07/2018
2Hypersensitivity (Allergy)
01/2020 - 03/2010
2Bulimia (Binge Eating)
12/2019 - 09/2012
2Neuralgia (Stump Neuralgia)
01/2019 - 07/2013
2Neuroblastoma
01/2019 - 03/2005
2Chronic Pain
01/2017 - 07/2013
1Atherosclerosis
06/2022
1Type 2 Diabetes Mellitus (MODY)
06/2022
1Nervous System Diseases (Neurological Disorders)
01/2022
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2022
1Multiple Sclerosis
01/2022
1Insulin Resistance
12/2021
1Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2021
1Dementia (Dementias)
01/2021
1Colitis
01/2020
1Chronic Cough
12/2019
1Stroke (Strokes)
01/2019
1Brain Ischemia (Cerebral Ischemia)
01/2019
1Hepatocellular Carcinoma (Hepatoma)
07/2018
1Colorectal Neoplasms (Colorectal Cancer)
07/2018
1Intestinal Diseases (Diseases, Intestinal)
01/2018
1Disease Progression
08/2015
1Endocrine System Diseases (Endocrine Diseases)
01/2015
1Cancer Pain
01/2015
1Infarction (Infarctions)
08/2014
1Migraine Disorders (Migraine)
07/2013
1Alcoholism (Alcohol Abuse)
02/2012
1Substance-Related Disorders (Drug Abuse)
02/2012
1Dry Eye Syndromes (Dry Eye Syndrome)
11/2010
1Rheumatoid Arthritis
11/2010
1Pathologic Processes
11/2010
1Tremor (Tremors)
03/2010

Drug/Important Bio-Agent (IBA)

13Purinergic P1 Receptors (Adenosine Receptor)IBA
06/2022 - 01/2007
8Adenosine (Adenocard)FDA LinkGeneric
06/2022 - 04/2005
7LigandsIBA
01/2022 - 01/2007
5Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
12/2019 - 04/2005
4Purinergic P1 Receptor AntagonistsIBA
01/2022 - 03/2007
3CytokinesIBA
02/2021 - 01/2020
3AdenineFDA LinkGeneric
02/2021 - 03/2005
2Adenosine A1 ReceptorIBA
12/2021 - 01/2019
2Protein Isoforms (Isoforms)IBA
09/2020 - 03/2010
2AntioxidantsIBA
01/2020 - 01/2019
2Purinergic P2X3 ReceptorsIBA
04/2019 - 01/2017
2Oxygen (Dioxygen)IBA
01/2019 - 06/2011
2Glucose (Dextrose)FDA LinkGeneric
01/2019 - 06/2011
2Glutamic Acid (Glutamate)FDA Link
01/2019 - 08/2015
2Pharmaceutical PreparationsIBA
07/2018 - 02/2007
2G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
07/2011 - 03/2010
2Anti-Inflammatory Agents (Anti-Inflammatories)IBA
11/2010 - 01/2009
28-ethoxy- 9-ethyladenineIBA
03/2010 - 04/2005
2Adenosine A2 Receptor AntagonistsIBA
06/2009 - 04/2005
29-ethyladenineIBA
06/2009 - 04/2005
1NucleosidesIBA
04/2022
1Cytostatic AgentsIBA
01/2022
1N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA
01/2022
1Casein Kinases (Casein Kinase)IBA
01/2022
1Proteins (Proteins, Gene)FDA Link
01/2022
1istradefyllineIBA
01/2022
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2021
1InterleukinsIBA
02/2021
1InterferonsIBA
02/2021
12'-deoxyadenosineIBA
02/2021
1Cholinesterase Inhibitors (Anticholinesterases)IBA
01/2021
1IsoenzymesIBA
09/2020
1hydroxide ionIBA
09/2020
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2020
12,4-dinitrofluorobenzene sulfonic acidIBA
01/2020
12,4-dinitrobenzeneIBA
01/2020
1Sulfonic AcidsIBA
01/2020
1Neuroprotective AgentsIBA
01/2020
1Adenosine A3 ReceptorIBA
01/2020
1PyridinesIBA
12/2019
1BLU-5937IBA
12/2019
1GefapixantIBA
12/2019
1CalciumIBA
01/2019
1Reactive Oxygen Species (Oxygen Radicals)IBA
07/2018
1Antineoplastic Agents (Antineoplastics)IBA
07/2018
1purineIBA
01/2018
1Drug CombinationsIBA
08/2015
1Levodopa (L Dopa)FDA LinkGeneric
08/2015
12- (3- hydroxy- 3- phenyl- 1- propyn- 1- yl)- 5'- N- ethylcarboxamidoadenosineIBA
08/2014
12- (4- (2- carboxyethyl)phenethylamino)- 5'- N- ethylcarboxamidoadenosineIBA
09/2012
1Ethanol (Ethyl Alcohol)IBA
02/2012
1Purinergic P2 Receptors (ADP Receptor)IBA
06/2011
1Mitogen-Activated Protein KinasesIBA
06/2011
1Rhodopsin (Visual Purple)IBA
03/2010
1Tacrine (Cognex)FDA Link
03/2010

Therapy/Procedure

7Therapeutics
01/2022 - 11/2010